Skip to main content
Article thumbnail
Location of Repository

Molecular assays for the detection of microRNAs in prostate cancer

By Amara C Siva, Luke J Nelson, Chad L Fleischer, Mehrdad Majlessi, Michael M Becker, Robert L Vessella and Mark A Reynolds
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2008). A Role for microRNA Alterations in Melanoma Progression [abstract].
    2. (2008). Agarwal R: Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle
    3. (2008). AH: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.
    4. (2008). Allgayer H: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene
    5. (2008). AR: Single-primer nucleic acid amplification methods.
    6. (2007). Baloch ZW: Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol
    7. (2008). Barshack I: MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol
    8. (2008). CB: RNAi and chromatin in T cell development and function. Curr Opin Immunol
    9. (2008). Chinnaiyan AM: Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. Cancer Res
    10. (2008). Chinnaiyan AM: Recurrent gene fusions in prostate cancer. Nat Rev Cancer
    11. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA
    12. (2008). Condorelli G: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene
    13. (2006). Coukos G: microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA
    14. (2006). Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA
    15. (2005). Croce CM: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
    16. (2002). Croce CM: Frequent deletions and down-regulation of micro-
    17. (2008). Croce CM: Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res
    18. (2004). Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA
    19. (2006). Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer
    20. (2001). DP: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science
    21. (2006). Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res
    22. (2006). Genetic aberrations in prostate cancer by microarray analysis.
    23. (2005). Guegler KJ: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res
    24. (2008). Latham GJ: Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA
    25. (2006). Majlessi MR: Methods and compositions to detect nucleic acids in a biological sample. US patent application
    26. (2008). Majumder S: MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27(Kip1).
    27. (2007). MG: miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.
    28. (2008). MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene
    29. (2008). Mo YY: MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res
    30. (2004). Mourelatos Z: Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods
    31. (2006). MU: A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA
    32. (2007). PS: MicroRNAs and cell cycle regulation. Cell Cycle
    33. (2005). quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA
    34. (2007). Sheils O: Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells.
    35. (2007). Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA
    36. (2008). Szafranska AE: Evaluation and Validation of Total RNA Extraction Methods for MicroRNA Expression Analyses in Formalin-Fixed, Paraffin-Embedded Tissues. J Mol Diagn
    37. (2007). The role of microRNAs in cancer: no
    38. (2005). TR: MicroRNA expression profiles classify human cancers. Nature
    39. (2003). Tuschl T: New microRNAs from mouse and human. RNA
    40. (2002). Visakorpi T: Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization. Genes Chromosomes Cancer
    41. (2007). Visakorpi T: MicroRNA expression profiling in prostate cancer. Cancer Res
    42. (2007). YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.